...

13/12/2014

. Md.Phd
/

/



s.s



Sc

 65 2
52 ,
.


.
.
( bA1c 8%),
.

.
.

)
)
)
)
)



50-70%

10-15

: ~80.000

85%
, :
50-70%

:
20-50%

Reiber et al. National Institute of Health, 1995

89
: 58,4%
: 65,513,5
13,5% (12 ) 1
63,9%
63,75%
16,3%
12,8%
29,8%

( NNS score) 44,95%

& . , 2013

 -



50%
4
77%

,

Cost of foot ulcers

Atlas of the Diabetic Foot, 2nd Edn, 2010, Wiley-Blackwell

)
)
) +
)
)

;
1)
2)
.
3) 1+2
4)
5) BMI

:
Kings College, London:
62%
25%
13%
Manchester:
40%
45%
15%
:

44%
28%
28%
:
56%
25%
19%

: 70-80%

&

) 2%
) 4%
) 5%
) 7.5%
) 10%

Diabetic foot. In: Vascular Surgery, Liapis Ch (Eds), Sringer-Verlag, Berlin, 2005


:
1) 7,5% (SE=1,4)
2) (MS1) 35,7% (SE=1,24)
3) (NS2) 43,2% (SE=1,2)
Manes et al., Wounds 2008

) 2
) 3
) 4
) 5
) 3



()
()

()

N. Katsilambros et al., Atlas of the Diabetic Foot, 2003, Wiley, UK

-


()

 SemmesWeinstein
5,07:
10-

Pham H et al. Screening techniques to identify people at risk for diabetic foot
ulceration: a prospective study. Diabetes Care 2000, 23: 606-611

Semmes Weinstein Monofilament

( 10)

128 Hz

 C ( ,
)
( )


> 25 Volts:
4-
10
< 13
Volts

Young MJ et al. The prediction of diabetic neuropathic foot ulceration using

Vibration perception thresholds. Diabetes Care 1994, 17: 557-561

=0
=1

0/1

( 128
Hz)

=0
=1

0/1

(
-)

=0
=1

0/1

=0
=1
=2

Boulton AJM, Malik RA. Diabetic neuropathy. Med Clin N Am 1998, 82: 909-929

0 / 1/ 2

Assessment of sudomotor function

The indicator plaster Neuropad
A measure of sweat production on the basis of colour
change from blue to pink

Neuropad have been shown to have high sensitivity in

detecting peripheral neuropathy in patients with type 2
diabetes

Zick R et al Klinikarzt 2003;32:192-94

Papanas N et al Exp Clin Endocrinol Diabetes 2005;113:195-98

 2011:

2

, ..

,


()

()
()



3cm. .
.
?

)
)
)

 2013:

(, , , ,
, , )


()


()


Gram (+) ,
()
,

( )

 2013:

( )


(
)

 2013:

( ,
,
) ()

()

()

(

) ()




55 66,1 5,1
74 :
24,32% CNS-staphylococci
14,86% St.Aureus ( 3
MRSA)
13,51% E.Coli
9,45% Ps.Aeruginosa
8,10% Pr.Mirabilis
6,75% E.Faecalis
4,05% St.Maltophilia
4,05% Citrobacter spp
4,05% Ent.Cloacae
2,70% Kl.Oxytoca
2,70% Serratia spp
2,70% Acinetobacter spp
2,70% Bacteroides spp
1,35% Flaribacterium
1,35% Str.Agalactiae

:
HbA1c,
, ,

:
MRSA
HbA1C , &

& ., 2013

)
)
)
) CRP
)
) ++

)
) 20% > 40
) 50% > 50
) +
)


,
, ,

2-4 .
40-50
20% 50
30%.
27%

5 4% .
2013



(
)





2013

,

/

b
c
a
(5%) d

 58
24 ,
15

.
.
.

.
.

)
) (N.Charcot)
)
)
)




:
)
) ()
)

 : Screening
ADA 2013 ,2014

, 5

. .
()

()
Screening
5
.
()
..

()

Diabetes Care 2012;suppl1

Diab. Care 2013;suppl1;s11-s51

 :
ADA 2012 ,2013

:
, ,
(10g. ,
, , , ... ()

screening
,
() ( C )

()

,
,

(, ) (C)
Diabetes Care 2012;suppl1
Diab. Care 2013;suppl1;s11-s51